期刊文献+

伊维菌素对宫颈癌Hela细胞增殖和凋亡的影响

Effect of ivermectin on proliferation and apoptosis of cervical cancer Hela cells
下载PDF
导出
摘要 目的探讨伊维菌素对人宫颈癌Hela细胞增殖和凋亡的影响。方法0.1、1、3μmol/L伊维菌素处理Hela细胞,MTT、Edu法检测细胞活性,流式细胞术检测细胞凋亡,蛋白印迹检测p-JNK、JNK、NF-κB p65、Bcl-2、Caspase-3、Caspase-9表达。结果伊维菌素呈浓度依赖性抑制Hela细胞增殖、诱导凋亡(P<0.01),上调p-JNK、Caspase-3、Caspase-9表达,下调NF-κB p65、Bcl-2表达。结论伊维菌素可能通过上调JNK信号通路诱导Hela细胞凋亡,下调NF-κB信号通路抑制Hela细胞增殖。 Objective To investigate the effect of ivermectin on proliferation and apoptosis of cervical cancer Hela cells.Methods After treated with 0.1,1,3μmol/L ivermectin,viability,apoptosis,and expression of p-JNK,JNK,NF-κB p65,Bcl-2,Caspase-3 and Caspase-9 in Hela cells were determined by MTT,Edu,flow cytometry,Western blot,respectively.Results Ivermectin inhibited proliferation,induced apoptosis(P<0.01),up-regulated expression of p-JNK,Caspase-3 and Caspase-9,and down-regulated expression of NF-κB p65 and Bcl-2 in Hela cells in a dose-dependent manner.Conclusion Ivermectin could induce apoptosis via up-regulation of JNK pathway and inhibit proliferation through down-regulation of NF-κB signaling in Hela cells.
作者 金亚玲 王祥珍 刘厚聪 孟军 JIN Ya-ling;WANG Xiang-zhen;LIU Hou-cong;MENG Jun(Department of Gynecology and Obstetrics,Nanshan Maternal and Child Health Hospital,Shenzhen 518067,China;Central Laboratory,Shenzhen Union Hospital,Huazhong University of Science and Technology,Shenzhen 518067,China;Department of Gynecology and Obstetrics,Shenzhen Union Hospital,Huazhong University of Science and Technology,Shenzhen 518067,China)
出处 《广东医科大学学报》 2020年第4期391-394,共4页 Journal of Guangdong Medical University
基金 广东省医学科学技术研究基金项目(No.C2017034)。
关键词 伊维菌素 HELA细胞 增殖 凋亡 ivermectin Hela cells proliferation apoptosis
  • 相关文献

参考文献2

二级参考文献29

  • 1IANARO A, IALENTI A, MAFFIA P,et al. Anti-inflammatory activity of macrolide antibiotics [J]. J Pharmacol Exp Ther ,2000,292(1) : 156-163.
  • 2HAJIME T, KAZUHITO A, KEN-ICHI K, et al. Suppressive activity of maerolide antibiotics on nitric oxide production by lipopolysaceharide stimulation in mice [J]. Mediators Inflamm, 2003,12 (4) : 195-202.
  • 3CAUMES E, DANIS M. New indications of ivermectin[J]. Rev Med Intern, 2001,22 (4) : 379-384.
  • 4GEARY T G. Ivermectin 20 years ont maturation of a wonder drug[J]. Trends Parasitol, 2005,21 (11) :530-532.
  • 5RICHARD-LENOBLE D, CHANDENIER J, GAXOTTE P. Ivermectin and filariasis[J]. Fundam Clin Pharmacol, 2003, 17(2) : 199-203.
  • 6SAJID M S,IQBAL Z,MUHAMMAD G,et al. Immunomodulatory effect of various anti-parasitics:a review[J]. Parasitology,2006,132(Pt 3) :301-313.
  • 7STANKIEWICZ M, CABAJ W, JONAS W E, et al. Influence of ivermectin on cellular and humoral immune responses of lambs[J]. Vet Immunol Immunopathol, 1995,44 (3/4) : 347- 358.
  • 8VIKTOROV A V, YURKIV V A. Effect of ivermectin on function of liver maerophages[J].Bull Exp Biol Med, 2003, 136(6) :569-571.
  • 9VIKTOROV A V. Ivermectin inhibits activation of Kupffer cells induced by lipopolysaccharide toxin[J]. Antibiot Khimioter, 2003,48 (4) : 3-6.
  • 10ZHANG X M,SONG Y,XIONG H Z,et al. Inhibitory effects of ivermectin on nitric oxide and prostaglandin E2 production in LPS-stimulated RAW 264.7 macrophages[J]. Int Immunopharmacol, 2009,9(3) : 354-359.

共引文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部